Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 ng/kg/Min) in Mechanically Ventilated Patients With Infectious Pulmonary Endotheliopathy - a Multicenter Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial

NCT06319274 is registered in ClinicalTrials.gov with Pär Johansson as lead sponsor.

NCT NCT06319274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 ng/kg/Min) in Mechanically Ventilated Patients With Infectious Pulmonary Endotheliopathy - a Multicenter Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial
Lead sponsor
Pär Johansson
Phase
Phase 2
Overall status
Recruiting
Start date
April 15, 2024
Completion date
September 30, 2027
Enrollment
450 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, endothelial dysfunction, pulmonary infection